Last updated on March 2019

BAY81-8973 Pediatric Safety and Efficacy Trial

Brief description of study

The objective of the study is to demonstrate the safety and efficacy of treatment with BAY81-8973 for prophylaxis and breakthrough bleeds in children with severe haemophilia A.

Clinical Study Identifier: NCT01311648

Contact Investigators or Research Sites near you

Start Over

Bayer Clinical Trials Contact

Esplugues de LLobregat, Spain
  Connect »

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.